Lataa...
Atypical Femoral Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research
Bisphosphonate (BP) is a useful anti-resorptive agent which decreases the risk of osteoporotic fracture by about 50%. However, recent evidences have shown its strong correlation with the occurrence of atypical femoral fracture (AFF). The longer the patient takes BP, the higher the risk of AFF. Also,...
Tallennettuna:
| Julkaisussa: | J Bone Metab |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Korean Society for Bone and Mineral Research
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4572036/ https://ncbi.nlm.nih.gov/pubmed/26389082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11005/jbm.2015.22.3.87 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|